Related Experiment Video

Updated: Oct 26, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Cloning and expression of recombinant antibody Fab genes of anti-c-myc peptide

L Li1, J Sun, L Wang

  • 1Australian National Liver Transplantation Unit, Royal Prince Alfred Hospital, Sydney, Australia.

Transplantation Proceedings
|December 5, 1998
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Related Experiment Videos

Last Updated: Oct 26, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells
10:32

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...

Articles linked to this work by shared authors, journal, and citation graph.

A giant multiacinar macroregenerative nodule in an explanted liver.

Transplantation·2001

Sequential transplantation induces islet allograft tolerance.

Microsurgery·2001

Antigenic load and peripheral chimeric levels in entire and partial liver allograft recipients.

Microsurgery·2001

A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts.

Transplantation·2001

Inferior liver allograft survival from cadaveric donors >50 years of age?

Clinical transplantation·2001

Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.

Transplantation·2001

Sodium-Glucose Cotransporter-2 Inhibitor Use in Kidney Transplant Recipients With Post-Transplantation Diabetes Mellitus - A Cross-Sectional Study.

Transplantation proceedings·2026

Exploration on Life Education in Deceased Organ Donation in China.

Transplantation proceedings·2026

Evaluation of CYP3A Phenoconversion in Immunosuppressed Patients Following Kidney Transplantation.

Transplantation proceedings·2026

Rapid Progression of Cardiac Allograft Vasculopathy With Sudden Cardiac Death Within the First Year of Heart Transplantation: A Case Report.

Transplantation proceedings·2026

Short and Long-Term Results of Kidney Transplantation From Extended Criteria Donors.

Transplantation proceedings·2026

Post-Transplant Lymphoproliferative Disorder After Successful Treatment of Graft-Versus Host Disease Following Liver Transplantation.

Transplantation proceedings·2026

Frequency of Bloodwork in Patients on Immune Checkpoint Inhibitors.

Current oncology (Toronto, Ont.)·2026

Immunotherapy in Liver Transplant Recipients with Advanced Solid Malignancies: A Three-Patient Case Series.

Current oncology (Toronto, Ont.)·2026

Cancer Immunotherapy and Immune-Related Adverse Events: Focusing on Non-Small Cell Lung Cancer.

Current oncology (Toronto, Ont.)·2026

Cell-Based Assay Development and Standardization for Antibody-Drug Conjugates.

Biotech (Basel (Switzerland))·2026

Switching Beyond Rituximab in Primary Glomerular Diseases: A Systematic Review of Within-Patient Efficacy and Safety of Non-Rituximab Anti-CD20 Antibodies.

Antibodies (Basel, Switzerland)·2026

Molecular Characterisation of the Nuclear Localisation Sequence Binding Properties of Toxoplasma gondii Importin α.

Cells·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us